Filing Details
- Accession Number:
- 0001127602-22-022417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-14 16:17:23
- Reporting Period:
- 2022-09-12
- Accepted Time:
- 2022-09-14 16:17:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760669 | Stephen Hoge | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-12 | 5,000 | $10.90 | 1,630,800 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-12 | 5,000 | $141.66 | 1,625,800 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-13 | 1,972 | $10.90 | 1,627,772 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-13 | 1,972 | $136.42 | 1,625,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-09-12 | 5,000 | $0.00 | 5,000 | $10.90 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-09-13 | 1,972 | $0.00 | 1,972 | $10.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,972 | 2026-02-23 | No | 4 | M | Direct | |
| 0 | 2026-02-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,116 | Indirect | By Valhalla, LLC |
| Common Stock | 151,933 | Indirect | By Trust |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.
- These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
